Search clinical trials for: follitropin beta

Total 6101 results

Genzyme, a Sanofi Company

Completed

A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease

Fabry Disease

Japan
RegeneRx Biopharmaceuticals, Inc.

Completed

Study of Thymosin Beta 4 in Patients With Pressure Ulcers

Pressure Ulcers

United States
Marilia Medicine School

Completed

Pterygium Treatment Using Single Beta-therapy as Adjuvant Treatment Compared to Conjunctival Autograft

Pterygium

Brazil
RegeneRx Biopharmaceuticals, Inc.

Withdrawn

A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction

ST Elevation Myocardial Infarction | Acute Myocardial Infarction | STEMI
Bayer

Completed

Physical Disability in Patients Treated With Betaferon

Multiple Sclerosis

Colombia
Metabolic Technologies Inc.
Iowa State University

Completed

Effects of HMB Supplementation on Recovery Following ACL Surgery

ACL Injury

United States
Western Galilee Hospital-Nahariya

Unknown

Prevention of Contrast Induced Nephropathy by Erythropoietin

Diabetes | Chronic Kidney Insufficiency

Israel
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis (IMPROVE)

Multiple Sclerosis, Relapsing-Remitting
Cinnagen

Completed

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis (RRMS)

Iran, Islamic Republic of
Biocad

Completed

Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers

Healthy

Russian Federation
Centre Hospitalier Universitaire Vaudois
BioPartners GmbH

Completed

Phase I BP Interferon (IFN) Beta-004

Multiple Sclerosis, Relapsing-Remitting
Koneksa Health

Completed

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist (LEARN)

Moderate Asthma

United States
Genzyme, a Sanofi Company

Terminated

Study of the Effects of Fabrazyme Treatment on Lactation and Infants

Fabry Disease | Alpha Galactosidase A Deficiency

United States, Austria, United Kingdom
Sunstar Americas

Completed

Case Series of New Alloplastic Bone Graft Material

Oral Surgery | Periodontology

United States
Green Cross Corporation

Unknown

Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Mucopolysaccharidosis II
Genzyme, a Sanofi Company
CRL/Medinet

Terminated

Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme

Fabry Disease | Chronic Kidney Disease, Stage IV (Severe)

United States
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Fabry Disease

United States, United Kingdom, Canada, Czech Republic, Hungary, Poland
Biogen

Completed

Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants.

Healthy

United Kingdom
Biotec Pharmacon ASA

Terminated

Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

Burns

Norway
Genzyme, a Sanofi Company

Completed

A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.

Fabry Disease

Japan
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Fabry Disease

Czech Republic, Estonia, Poland, Slovakia
Genzyme, a Sanofi Company

Completed

A Study of Fabrazyme in Pediatric Patients With Fabry Disease

Fabry Disease

United States, France, Poland, United Kingdom
Synthes USA HQ, Inc.

Completed

Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate

Degeneration of Lumbar Intervertebral Disc

United States
Hadassah Medical Organization

Completed

Beta Glucosylceramide for Treatment of NASH

Compliance Behavior
Boston University

Completed

Fresolimumab In Systemic Sclerosis

Diffuse Systemic Sclerosis

United States
Biotec Pharmacon ASA

Completed

The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients

Oral Mucositis

Germany, United Kingdom
Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic... and other conditions

United States
Universidad Católica San Antonio de Murcia

Completed

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists (B-AC1)

Beta Alanine Supplementation

Spain
Bayer

Completed

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron (START)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
Universidad Católica San Antonio de Murcia

Recruiting

Study to Analyze the Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists (B-AC2)

Beta Alanine Supplementation

Spain
Universidad Católica San Antonio de Murcia

Recruiting

Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists (B-AC3)

Beta Alanine Supplementation

Spain
Azienda Ospedaliero-Universitaria Consorziale Policlinico...
University of Bari

Completed

ProAliFun_6.5_Health Effects of a Functional Pasta Enriched With Barley Beta-glucans on Healthy Subjects (ProAliFun65)

Healthy

Italy
Chris Goss
Medical University of South Carolina; University of Washington; Cystic Fibrosis...

Recruiting

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study (STOP360AG)

Cystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation

United States, Canada
Faron Pharmaceuticals Ltd

Completed

Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II

Acute Respiratory Distress Syndrome | Acute Lung Injury

United Kingdom
IBSA Institut Biochimique SA

Completed

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (FAST)

Infertility

Italy, Belgium, Turkey, Spain, Switzerland, United Kingdom
EMD Serono
Pfizer

Completed

RNF and Betaseron® Tolerability Study (REFORMS)

Relapsing Remitting Multiple Sclerosis (RRMS)

United States
EMD Serono
Merck Serono International SA

Completed

Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis

Ulcerative Colitis

Sweden, Germany, Netherlands, Israel, Singapore, Switzerland, United Kingdom
Reproductive Specialists of New York

Completed

AMH and Dosing Regimens for Initial IVF Stimulation Protocols

Infertility
Biogen

Completed

Plegridy Satisfaction Study in Participants (PLATINUM)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Italy
Università Vita-Salute San Raffaele

Completed

Esmolol in Cardiac Surgery (BREVI)

Cardiac Surgery

Italy
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Behavioral Pharmacology of THC and Beta-Myrcene

Cannabis Use

United States
MedtronicNeuro

Terminated

LFP Beta aDBS Feasibility Study

Parkinson Disease

United States
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease

Fabry Disease

United States, United Kingdom, Canada, Hungary, Poland, Czech Republic
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia (VITAL)

Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic Syndrome | Myeloid Sarcoma | Acute Myeloid Leukemia With Multilineage Dysplasia

United States
Singapore Institute for Clinical Sciences
DSM Nutritional Products, Inc.

Completed

Beta-cryptoxanthin Supplement: Absorption and Function (BETA+)

Beta-cryptoxanthin Supplementation

Singapore
Nancy Hammond, MD
Kansas City Area Life Sciences Institute, Inc.

Completed

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

Multiple Sclerosis | Low Bone Density

United States
Peking University Third Hospital

Not yet recruiting

Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle

Infertility, Female
University of Calgary

Unknown

Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain

Diabetic Neuropathies

Canada
Biogen

Completed

Plegridy Observational Program (POP)

Relapsing Forms of Multiple Sclerosis

United States, Italy, Switzerland, Canada, Australia, Germany, Spain, France, Portugal, Netherlands, United Kingdom, Denmark, Austria, Ireland

Search clinical trials for: follitropin beta

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations